Heteroaryl pyridone and aza-pyridone compounds are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using heteroaryl pyridone and aza-pyridone compounds for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
提供了杂环
吡啶酮和氮杂
吡啶酮化合物,包括立体异构体、互变异构体和药学上可接受的盐,用于抑制Btk激酶,并治疗由Btk激酶介导的免疫紊乱,例如炎症。公开了使用杂环
吡啶酮和氮杂
吡啶酮化合物进行哺乳动物细胞中的体外、体内和原位诊断和治疗这种疾病或相关病理条件的方法。